|
||
By

From the * Divisions of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess
Medical Center, West Campus, Harvard Institutes of Medicine, Harvard Medical School, Boston,
Massachusetts 02215; and the The related adhesion focal tyrosine kinase (RAFTK), a recently discovered member of the focal adhesion kinase family, has previously been reported to participate in signal transduction in
neuronal cells, megakaryocytes, and B lymphocytes. We have found that RAFTK is constitutively expressed in human T cells and is rapidly phosphorylated upon the activation of the T cell receptor (TCR). This activation also results in an increase in the autophosphorylation and kinase activity of RAFTK. After its stimulation, there was an increase in the association of the src cytoplasmic tyrosine kinase Fyn and the adapter protein Grb2. This association was mediated
through the SH2 domains of Fyn and Grb2. RAFTK also co-immunoprecipitates with the
SH2 domain of Lck and with the cytoskeletal protein paxillin through its COOH-terminal proline-rich domain. The tyrosine phosphorylation of RAFTK after T cell receptor-mediated
stimulation was reduced by the pretreatment of cells with cytochalasin D, suggesting the role of
the cytoskeleton in this process. These observations indicate that RAFTK participates in T cell
receptor signaling and may act to link signals from the cell surface to the cytoskeleton and
thereby affect the host immune response.
Division of Hematology/Oncology, Oregon Health Sciences Center,
Portland, Oregon 97201
This article has been cited by other articles:
| TABLE OF CONTENTS |
|